BioProcess International (BPI) | Conference and Exhibition (2026)

Event Snapshot (Verified from Official Website)

• Event title: BioProcess International (BPI) | Conference and Exhibition
• Dates: September 22–25, 2026
• Venue: Hynes Convention Center
• City & Country: Boston, USA
• Positioning: Bioprocessing breakthroughs for manufacturing reality (scale-up, GMP readiness, CMC strategy, and digital biomanufacturing)
• Core pillars explicitly referenced: Cell Line, Upstream, Downstream, Digital Biomanufacturing, CMC Strategy, Cell & Gene Therapy

Why This Event Matters for Bioprocessing Buyers

BioProcess International is built around the full biomanufacturing lifecycle—from engineering and development of cell lines through upstream and downstream process optimization, then into digital biomanufacturing and CMC strategy for reliable, regulator-ready biologics manufacturing. The event’s agenda themes strongly indicate that the strongest business buyers are not generic “industry visitors,” but technical and commercial stakeholders who influence technology selection, vendor evaluation, and implementation decisions across cell line development and biomanufacturing operations.

The official event messaging also emphasizes cross-functional outcomes: reduce scale-up surprises, strengthen CMC, optimize processes, and integrate AI/digital tools to improve reliability and timeline performance. This positioning creates a concentrated environment where buyer attention tends to cluster around specific technology categories (e.g., purification development, process monitoring and data science/AI strategy, cell culture and cell line development, and cell & gene therapy manufacturing readiness).

1️⃣ Who Attends (BUYERS / ATTENDEES)

BioProcess International is designed as a professional, technology- and science-led gathering. The official website explicitly indicates attendance includes 3,000+ bioprocessing professionals, as well as solution & technology providers and expert speakers. Based on the event pillars (cell line development & engineering, upstream & cell culture, downstream, digital biomanufacturing, CMC strategy, and cell & gene therapy), the “buyer” attendees we typically prioritize are those with ownership or strong influence over bioprocess development, manufacturing readiness, and technology evaluation.

Primary buyer/decision-maker attendee groups

• Bioprocess R&D leadership: leaders responsible for upstream/downstream process development, process engineering, scale-up, and process robustness.
• Cell line development and engineering leaders: executives/managers who drive CHO and other cell line workflows, including clone selection, stability testing, expression systems, and automation approaches.
• CMC strategy leaders: stakeholders aligning manufacturing process with regulatory expectations, comparability, and GMP readiness for biologics.
• Digital biomanufacturing / AI / data science leaders: roles covering process monitoring, data science, process analytics, and AI strategy for manufacturing performance and control.
• Cell & gene therapy development/manufacturing leaders: senior leadership involved in manufacturing/supply & quality for advanced therapies.
• Purification development and downstream leaders: roles overseeing purification strategies, yield improvement, quality attributes, and tech stack selection.
• Corporate technology and operations leaders: technical operations leaders and executives overseeing implementation of process and manufacturing technologies.

Supporting attendee groups (also valuable for engagement)

• Solutions & technology providers (exhibitors, suppliers, and service partners) seeking technical conversations with development and manufacturing leaders.
• Scientific poster presenters and researchers (useful for identifying innovation teams and innovation-driven buying cycles).

2️⃣ Where the Show Is Happening + Attendee Geographic Origin

Show location: Hynes Convention Center, Boston, USA.

The official website states “countries represented,” but it does not provide a numeric breakdown in the excerpt we were given. What we can reliably say is that BioProcess International is positioned for global bioprocessing professionals, and it explicitly highlights “countries represented,” indicating international participation in addition to strong U.S. presence.

Practical geographic targeting for buyer research

• United States (core): Boston is a major hub for biotech, bioprocessing talent, and biomanufacturing innovation. We should expect a strong concentration of U.S.-based development and manufacturing professionals.
• North America (secondary but strong): Canada and other North American biotech/biopharma clusters are typically represented for science and manufacturing conferences in this segment.
• Europe (likely): European bioprocessing and cell therapy leadership frequently attends technology-focused conferences tied to CMC and GMP readiness.
• Asia-Pacific (likely): International participation is suggested by the “global bioprocessing professionals” positioning; many APAC companies attend to evaluate upstream/downstream and digital biomanufacturing solutions.

3️⃣ Audience Reach (Local / National / Global)

BioProcess International is best classified as global in reach with a strong U.S. anchor.

• Global: The official website explicitly highlights “global bioprocessing professionals” and mentions “countries represented.”
• U.S.-centered: The event takes place in Boston, and the buy-in categories (cell line development, upstream/downstream, CMC strategy, digital manufacturing, and cell & gene therapy manufacturing readiness) are highly active across U.S. biopharma organizations.

4️⃣ Sample Buyer Company Names (BUYERS ONLY) + Websites

Below we provide buyer-style examples aligned to the event’s thematic pillars (cell line development, downstream purification, CMC strategy, digital/AI biomanufacturing, and cell & gene therapy manufacturing). These are designed to be “buyers-only” (biopharma / biotech / therapeutic developers and relevant technical operations organizations) rather than generic exhibitors.

Important: We can refine the buyer list further once we review your client product positioning and target buyer persona.

Top 5 best sample buyer targets to start with (from the event’s named context):
Biogen, Sanofi, Regeneron, Genentech, AstraZeneca.
These map strongly to the event’s speaker/leadership themes across cell line, upstream/downstream, CMC strategy, digital monitoring, and cell/gene therapy manufacturing.

5️⃣ Job Profiles, Industries & Event Type

Best job profiles to target (buyer decision power)

• Cell line development & engineering: Head of Cell Culture and Cell Line Development; Director of Cell Line Development; Lead Engineer for CHO clone selection; Manager, Stability Testing.
• Downstream & purification: Global Head of Purification Development; Director, Downstream Process Development; VP, Purification Development.
• Upstream & cell culture process optimization: Upstream Process Development Director; Program Manager for ATF/TFF/perfusion optimization; Lead for harvest and retention methods.
• Digital biomanufacturing & AI: Head of Process Monitoring & Data Science/AI Strategy; Director, Digital Manufacturing; Manager, Process Analytics.
• CMC strategy: Director, CMC Strategy; CMC Program Lead; Manufacturing Strategy & Regulatory Alignment Lead.
• Cell & gene therapy manufacturing: VP/Director, Cell Therapies Development, Manufacturing, Supply & Quality; Technical Operations leaders in advanced therapy organizations.
• Technical operations & enterprise manufacturing: CTO/SVP Technical Operations; Global Head, Biomanufacturing Technology.

Industries we should map for research & targeting (from the provided industry taxonomy)

We recommend prioritizing the following industry filters because they map directly to bioprocessing technology adoption, biomanufacturing, and professional services around advanced therapies:

• Pharmaceuticals
• Biotechnology
• Hospital & Health Care (secondary, for translational/clinical manufacturing-adjacent groups)
• Medical Devices (secondary; relevant only for manufacturing systems intersecting bioprocess hardware/software)
• Research (secondary; for organizations translating research into pilot/manufacturing workflows)
• Computer Software and Information Technology & Services (secondary; if your client sells digital biomanufacturing, analytics, or AI workflow platforms)
• Professional Training & Coaching (only if your client provides specialized training/compliance enablement)

Event type (what it is, in buyer terms)

BioProcess International functions as a biomanufacturing technology conference and exhibition, with technical sessions/workshops and case-study forums focused on:

• Scale-up and GMP readiness
• Cell line development workflows
• Upstream and downstream process optimization
• Digital biomanufacturing and AI-enabled process monitoring/strategy
• CMC strategy for advanced biologics and cell/gene therapies

6️⃣ Estimated Attendance (Expected Total Footfall)

The official website excerpt specifies 3000+ bioprocessing professionals attending. It also implies additional categories (solution & technology providers, speakers, scientific posters). Based on what is explicitly available, the most defensible “expected total footfall” for planning outreach is:

• Estimated attendance: 3,000+ total bioprocessing professional attendees (official stated baseline)
• Exhibition and engagement multiplier: additional exhibitors/speakers/poster contributors are present, but the exact total number beyond the 3,000+ figure is not provided in the supplied text.

If we receive your outreach goals (e.g., leads from specific pillars such as downstream/purification vs. digital/AI vs. cell line engineering), we can propose tighter attendee segmentation without inflating numbers that are not explicitly stated.

7️⃣ Key Focus Areas & Buyer Engagement

Key focus areas (directly tied to the official pillars)

1. Cell Line Development & Engineering
   Accelerate cell line development for First-In-Human (FIH) by integrating proven workflows and ensuring regulatory and quality compliance. Includes clone selection, stability testing, and approaches involving automation and digital tools.
2. Upstream & Cell Culture
   Optimize cell retention and harvest methods using ATF (Alternating Tangential Flow), TFF (Tangential Flow Filtration), and centrifugation techniques. Improve yields in perfusion processes by managing lactate, ammonia, and osmolality.
3. Downstream
   Strengthen downstream and purification execution to deliver robust, reliable performance—aligned with reducing scale-up surprises and ensuring GMP-ready success.
4. Digital Biomanufacturing
   Integrate digital and AI approaches to enable process monitoring, control strategies, and improved predictability across manufacturing lifecycle stages.
5. CMC Strategy
   Strengthen CMC and align development and commercialization pathways so processes meet regulatory expectations with fewer surprises.
6. Cell & Gene Therapy
   Spotlight manufacturing readiness and development-to-operations strategies for advanced therapies.

What “buyer engagement” looks like in practice at this event

• Technical proof over marketing: many conversations are likely to center on process robustness, scale-up readiness, and measurable improvements (yield, quality attributes, timeline reduction).
• Use-case driven discussions: the official page references case-study forums and strategies to shorten timelines and increase efficiency.
• Cross-functional stakeholders: the strongest engagement often connects R&D process owners with CMC strategy and manufacturing operations leadership.
• Digital and AI adoption: roles related to data science/AI strategy and process monitoring are explicitly included via speaker positioning.

8️⃣ Client Product Fit: Buyer Selection Based on Your Requirements (We need your website)

We can absolutely narrow this event’s attendee universe to the best buyer profiles that match your client’s product requirements. However, the information provided so far does not include your client website or product description.

Please share these so we can produce the “best buyers” shortlist

• Your client website URL (required)
• What the client sells (1–2 lines)
• Who the end-users are (R&D, downstream ops, CMC, digital/data teams, QA/QMS, manufacturing execution, etc.)
• Primary use cases (e.g., purification optimization, cell line engineering acceleration, process monitoring/AI, compliance/CMC enablement)
• Preferred buyer geographies (optional)

How we will review and map your client to buyers at BPI 2026

After we review your client website, we will map your solution to one (or more) of the event pillars:

• If your client sells cell line development tools (automation, screening, stability workflows, CHO engineering support), we will prioritize cell line engineering leadership roles.
• If your client sells upstream solutions (ATF/TFF/perfusion optimization, sensors, control systems, media/feeding process enablers), we will prioritize upstream and cell culture process owners.
• If your client sells downstream/purification technologies (resins/process equipment/software, purification optimization, chromatography execution support), we will prioritize downstream and purification development leaders.
• If your client sells digital biomanufacturing / AI / process monitoring, we will prioritize process monitoring & data science/AI strategy roles plus manufacturing analytics leadership.
• If your client sells CMC strategy enablement (tools, documentation workflow systems, analytics for regulatory readiness), we will prioritize CMC strategy stakeholders.
• If your client supports cell & gene therapy manufacturing, we will prioritize cell therapy manufacturing/supply & quality leadership.

We will then deliver

• A ranked list of the best buyer company targets for this specific event
• A ranked list of best job titles to target inside those companies
• Suggested industry filters using your provided industry taxonomy
• Buyer-first messaging angles by pillar (so outreach matches how BPI frames its content)

9️⃣ Industry Recommendations (Using the Provided Industry Taxonomy)

Below is a “buyer-fit” industry map for BioProcess International, tuned for the pillars listed on the official event website:

• Primary:
  • Biotechnology
  • Pharmaceuticals
• Secondary (high-fit depending on your client offering):
  • Research
  • Computer Software
  • Information Technology & Services
  • Medical Devices (if the product intersects bioprocess equipment/hardware/system workflows)
  • Hospital & Health Care (if connected to translational manufacturing/quality workflows)
• Selective (only if your client’s product matches these angles):
  • Professional Training & Coaching (if training/compliance or workflow enablement is a major component)

Final Buyer-Research Recommendation (What We Suggest You Do Next)

BioProcess International 2026 in Boston is a highly targeted bioprocessing and manufacturing reality conference, with clear pillar coverage spanning cell line development, upstream and downstream optimization, CMC strategy, digital biomanufacturing, and cell/gene therapy. This structure naturally produces a dense cluster of technical and commercial “buyer personas” who care about measurable process reliability, timeline reduction, and GMP readiness.

To produce the most accurate “best buyers” shortlist for your client, we need your client website. Once we review it, we will return:

• Top buyer persona mapping by pillar
• A refined buyer company list (buyers only)
• Title-level targeting optimized for the event’s engagement areas

Next step

Please share your client website, and we will review it and recommend the best buyer types for BioProcess International (BPI) 2026 based on your product requirements.